PHASE-II CLINICAL-STUDY OF CIS-DICHLORODIAMMINEPLATINUM (CDDP) AND VP-16-213 (VP16) IN COMBINATION FOR PATIENTS (PTS) WITH EXTENSIVE NON-SMALL CELL LUNG-CANCER (E-NSCLC)

被引：0
|
作者：
DHINGRA, HM [1 ]
VALDIVIESO, M [1 ]
UMSAWASDI, T [1 ]
SPITZER, G [1 ]
MURPHY, WK [1 ]
CHIUTEN, DF [1 ]
BOOSER, DJ [1 ]
MOUNTAIN, CF [1 ]
机构：
[1] UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,HOUSTON,TX 77030
来源：
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1981年 / 22卷 / MAR期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：200 / 200
页数：1
相关论文
共 50 条
  • [41] CYCLOPHOSPHAMIDE, VINDESINE AND ORAL VP-16 IN THE TREATMENT OF NON-SMALL CELL LUNG-CANCER (NSCLC) - AN OUTPATIENT REGIMEN
    WEITBERG, AB
    CHEMOTHERAPY, 1988, 34 (02) : 155 - 157
  • [42] A MULTICENTER PHASE-II TRIAL OF CISPLATIN AND ORAL ETOPOSIDE (VP-16) IN INOPERABLE NON-SMALL-CELL LUNG-CANCER
    SPLINTER, T
    KOK, T
    KHO, S
    LAMERIS, H
    TENKATE, F
    DALESIO, O
    DOLMAN, B
    PALMEN, F
    BOUVY, J
    BURGHOUTS, J
    SIMONIS, F
    HARPER, P
    RANKIN, E
    VANREIJSWOUD, I
    VANHOOGENHUIJZE, J
    SEMINARS IN ONCOLOGY, 1986, 13 (03) : 97 - 103
  • [43] PRELIMINARY PHASE-II STUDY OF ADRIAMYCIN (ADM) IN PATIENTS WITH NON-SMALL CELL LUNG-CANCER (NSCLC)
    FUJITA, J
    SAIJO, N
    EGUCHI, K
    SHINKAI, T
    TOMINAGA, K
    SASAKI, Y
    SAKURAI, M
    FUTAMI, H
    ISHIHARA, J
    TAKAHASHI, H
    ISHIZUYA, Y
    HOSHI, A
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1985, 15 (02) : 365 - 368
  • [44] PHASE-II STUDY OF MITOXANTRONE IN PATIENTS WITH NON-SMALL CELL LUNG-CANCER
    SUGA, J
    SAIJO, N
    SHINKAI, T
    EGUCHI, K
    SASAKI, Y
    SAKURAI, M
    SANO, T
    TAMURA, T
    HOSHI, A
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1986, 16 (02) : 147 - 151
  • [45] PHASE-II TRIAL OF DAILY ORAL VP-16 IN REFRACTORY SMALL CELL LUNG-CANCER - A HOOSIER ONCOLOGY GROUP-STUDY
    EINHORN, LH
    PENNINGTON, K
    MCCLEAN, J
    SEMINARS IN ONCOLOGY, 1990, 17 (01) : 32 - 35
  • [46] 5-FLUOROURACIL INFUSION (FU), ETOPOSIDE (VP16) AND CISPLATIN (DDP) COMBINATION (FED) CHEMOTHERAPY (CT) IN NON-SMALL CELL LUNG-CANCER (NSLC)
    SRIDHAR, KS
    VARKI, J
    DONNELLY, E
    DAVILA, E
    BENEDETTO, P
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1985, 26 (MAR): : 171 - 171
  • [47] CISPLATIN (CDDP)-VP 16-213 COMBINATION CHEMOTHERAPY IN NON SMALL CELL (NSC) BRONCHOGENIC-CARCINOMA - PHASE I-II CLINICAL-TRIAL
    LONGEVAL, E
    DEJAGER, R
    TAGNON, H
    KLASTERSKY, J
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 368 - 368
  • [48] A RANDOMIZED STUDY COMPARING PLATINUM, DOXORUBICIN, AND VP-16 WITH PLATINUM, 4'-EPIDOXORUBICIN, AND VP-16 IN PATIENTS WITH NON-SMALL-CELL LUNG-CANCER
    ROSELL, R
    ABADESTEVE, A
    MORERA, J
    MONRAS, P
    MORENO, I
    RUIZ, J
    FERNANDEZ, C
    RIBASMUNDO, M
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1987, 10 (03): : 245 - 248
  • [49] PHASE-II STUDY OF UFT IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG-CANCER
    KEICHO, N
    SAIJO, N
    SHINKAI, T
    EGUCHI, K
    SASAKI, Y
    TAMURA, T
    SAKURAI, M
    SANO, T
    HOSHI, A
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1986, 16 (02) : 143 - 146
  • [50] THERAPEUTIC TRIALS WITH VP-16-213 AND VM-26 - ACTIVE AGENTS IN SMALL CELL LUNG-CANCER, NON-HODGKINS LYMPHOMAS, AND OTHER MALIGNANCIES
    RADICE, PA
    BUNN, PA
    IHDE, DC
    CANCER TREATMENT REPORTS, 1979, 63 (08): : 1231 - 1239
12345